Does ROZANOLIXIZUMAB Cause Dyspnoea? 29 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 29 reports of Dyspnoea have been filed in association with ROZANOLIXIZUMAB (RYSTIGGO). This represents 9.6% of all adverse event reports for ROZANOLIXIZUMAB.
29
Reports of Dyspnoea with ROZANOLIXIZUMAB
9.6%
of all ROZANOLIXIZUMAB reports
0
Deaths
19
Hospitalizations
How Dangerous Is Dyspnoea From ROZANOLIXIZUMAB?
Of the 29 reports, 19 (65.5%) required hospitalization, and 1 (3.4%) were considered life-threatening.
Is Dyspnoea Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ROZANOLIXIZUMAB. However, 29 reports have been filed with the FAERS database.
What Other Side Effects Does ROZANOLIXIZUMAB Cause?
Myasthenia gravis (158)
Headache (64)
Drug ineffective (54)
Diarrhoea (41)
Asthenia (36)
Fatigue (34)
Nausea (25)
Fall (22)
Therapeutic response shortened (22)
Pyrexia (19)
What Other Drugs Cause Dyspnoea?
ALBUTEROL (21,856)
TREPROSTINIL (16,348)
AMBRISENTAN (13,367)
PREDNISONE (12,830)
BUDESONIDE\FORMOTEROL (11,158)
TIOTROPIUM (10,863)
ADALIMUMAB (10,547)
DUPILUMAB (10,310)
FLUTICASONE\SALMETEROL (9,783)
MEPOLIZUMAB (9,192)
Which ROZANOLIXIZUMAB Alternatives Have Lower Dyspnoea Risk?
ROZANOLIXIZUMAB vs ROZANOLIXIZUMAB-NOLI
ROZANOLIXIZUMAB vs RUBIDIUM RB-82
ROZANOLIXIZUMAB vs RUCAPARIB
ROZANOLIXIZUMAB vs RUCAPARIB CAMSYLATE
ROZANOLIXIZUMAB vs RUFINAMIDE